Skip to main content

Median Technologies to host two webcasts on September 5, 2024

eyonis™ LCS: New Horizons in Fighting Lung Cancer”

Regulatory News:

Median Technologies (FR0011049824, ALMDT, PEA/SME eligible, “Median” or “The Company”) will host two live webcasts on September 5, 2024.

Following the recent release of results of the eyonis™ LCS REALITY study, Fredrik Brag, CEO and Founder of Median Technologies, will offer further insights into the significance of eyonis™ LCS and discuss the next steps for Median's novel Software as a Medical Device.

  • September 5, 2024 - 4:00 pm CEST / 10:00 am EDT (English): Sign-up Link
  • September 5, 2024 - 6:00 pm CEST / 12:00 pm EDT (French): Sign-up Link

Webcast replays will be available on Median’s corporate website shortly after the live sessions.

About Median Technologies: Pioneering innovative imaging solutions and services, Median Technologies harnesses cutting-edge AI to enhance the accuracy of early cancer diagnoses and treatments. Median's offerings include iCRO, which provides medical image analysis and management in oncology trials, and eyonis™, an AI/ML tech-based suite of software as medical devices (SaMD). Median empowers biopharmaceutical entities and clinicians to advance patient care and expedite the development of novel therapies. The French-based company, with a presence in the U.S. and China, trades on the Euronext Growth market (ISIN: FR0011049824, ticker: ALMDT). Median is also eligible for the French SME equity savings plan scheme (PEA-PME). For more information, visit www.mediantechnologies.com.

Contacts

Recent Quotes

View More
Symbol Price Change (%)
AMZN  218.68
-3.35 (-1.51%)
AAPL  260.34
-2.43 (-0.92%)
AMD  239.12
+1.09 (0.46%)
BAC  51.16
-0.37 (-0.71%)
GOOG  255.42
+4.08 (1.62%)
META  737.38
+4.11 (0.56%)
MSFT  522.88
+5.22 (1.01%)
NVDA  182.94
+1.78 (0.98%)
ORCL  275.75
+0.60 (0.22%)
TSLA  441.19
-1.41 (-0.32%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.